A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Clinical trial NCT05170958 · RECRUITING

Trial details

NCT number: NCT05170958
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-01-06
Primary completion: 2026-12-01
Enrollment: 396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.